Academic researchers from King's College London have investigated the early effects of an immunosuppressant drug that could help clinicians with future personalized approaches for the treatment of psoriasis.
Feb 19, 2024
0
19
In the largest study to date exploring the relationship between severe psoriasis and coronary microvascular dysfunction, researchers have found further evidence that patients with severe psoriasis are at higher cardiovascular ...
Sep 20, 2023
0
56
The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. Patients receiving the drug include those with moderate ...
Feb 7, 2023
0
2
Restless leg syndrome (RLS) is more common in psoriasis patients and is associated with more severe psoriasis, according to a study published online Dec. 5 in the International Journal of Dermatology.
Dec 15, 2022
0
7
Spinal injections of a common anesthetic may help clear the inflammatory skin condition psoriasis, a small pilot study suggests.
Aug 15, 2022
0
10
Four in 10 plaque psoriasis patients achieve complete disease clearance with tapinarof cream, 1 percent, according to a study published online June 26 in the Journal of the American Academy of Dermatology.
Jul 13, 2022
0
0
Women with psoriasis have a significantly increased risk for ectopic pregnancy (EP), which is highest for those with moderate-to-severe psoriasis, according to a study published in the June issue of JAAD International.
May 19, 2022
0
6
(HealthDay)—For adults with plaque psoriasis, tapinarof cream is better than vehicle control for reducing disease severity, according to a study published in the Dec. 9 issue of the New England Journal of Medicine.
Dec 9, 2021
0
3
The Psoriasis Area and Severity Index (PASI) clearance trajectory over the first few weeks of type B ultraviolet (UVB) phototherapy may predict psoriasis clearance, according to a study published in the November issue of ...
Oct 26, 2021
0
5
(HealthDay)—The use of patient-reported outcome measures (PROMs) to complement clinician-reported outcomes (CROs) may yield important information for assessing disease severity and guiding treatment of psoriasis, according ...
Sep 8, 2021
0
2
